Rocket Pharmaceuticals, Inc. Common Stock RCKT

$3.47 +3.89% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-08-13 View →
4 FORM 4 2026-08-13 View →
8-K 8-K 2026-08-10 View →
10-Q 10-Q 2026-08-10 View →
4 Insider transaction 2026-08-05 View →
4 Insider transaction 2026-08-05 View →
8-K 8-K 2026-08-03 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-06 View →
8-K 8-K 2026-06-30 View →
8-K 8-K 2026-06-12 View →
4 FORM 4 2026-05-28 View →
4 FORM 4 2026-05-26 View →
4 FORM 4 2026-05-21 View →
4 FORM 4 2026-05-21 View →
4 FORM 4 2026-05-21 View →
8-K 8-K 2026-05-21 View →
4 Insider transaction 2026-05-14 View →
4 Insider transaction 2026-05-14 View →
4 Insider transaction 2026-05-14 View →
4 FORM 4 2026-05-11 View →
8-K 8-K 2026-05-07 View →
10-Q 10-Q 2026-05-07 View →
8-K 8-K 2026-04-28 View →
DEF 14A DEF 14A 2026-04-06 View →
8-K 8-K 2026-03-27 View →
8-K 8-K 2026-03-10 View →
424B5 424B5 2026-03-10 View →
S-3 S-3 2026-03-02 View →
8-K 8-K 2026-02-26 View →
10-K 10-K 2026-02-26 View →
4 FORM 4 2026-02-20 View →
4 FORM 4 2026-02-20 View →
4 FORM 4 2026-02-20 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-02-18 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$3.47
Market Cap
$380.92 million
52-Week Range
$2.53 – $5.45
Average Volume
1.72 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.